DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Obermannová R, Van Cutsem E, Yoshino T. et al.
Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression.
Ann Oncol 2016;
27: 2082-2090
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.